CUPERTINO, Calif., May 03, 2022 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals
Since the beginning of the COVID-19 pandemic, the Pillar team has been continuing to put patient safety at the forefront. We have been following all CDC and state guidelines regarding operations and safe social distancing procedures. We will continue to conduct as much business as possible via phone calls and telehealth, where appropriate. All visitors to our sites are screened and temperature checked before entry. Proper PPE is also utilized by staff and provided for patients. We are continuing with several new studies and appreciate your continued support throughout these challenging times!
Sign up to receive updates, promotions, and sneak peaks of Swab Test.